NCT04036812

Brief Summary

The incidence of postoperative pain after craniotomy is high. Severe postoperative pain can lead to a series of complications that are detrimental to the recovery of craniotomy patients. Compound local scalp nerve block is a good choice for analgesia after craniotomy. However, the scalp nerve block commonly cannot cover the area of suboccipital retrosigmoid approach craniotomy, leading to incomplete block. Superficial cervical plexus block (SCPB) is theoretically promising to solve the analgesia requirements of such surgical approach. At the same time, ultrasound guidance can not only accurately locate, ensure the effect of block and avoid accidental injury during puncture. The purpose of this study is to explore whether ultrasound-guided superficial cervical plexus block can safely and effectively reduce the requirement of analgesic drugs and pain after craniotomy via suboccipital retrosigmoid approach.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2019

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 26, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 30, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

November 18, 2019

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 9, 2021

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2021

Completed
Last Updated

February 13, 2025

Status Verified

February 1, 2025

Enrollment Period

1.4 years

First QC Date

July 26, 2019

Last Update Submit

February 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • the cumulative consumption of sufentanil by the PCA

    the cumulative consumption of sufentanil by the PCA 24 hours after surgery

    24 hours after surgery

Secondary Outcomes (4)

  • Use of analgesics by the PCA after operation

    at 1, 2, 4, 48 hours after surgery.

  • Pain severity score

    at 1, 2, 4, 24, 48 hours after surgery

  • Anesthesia recovery quality score:

    at 1 hour after surgery

  • Patient analgesic satisfaction

    at 24 hours after surgery

Study Arms (2)

Superficial cervical plexus block group

EXPERIMENTAL
Procedure: Superficial cervical plexus block

Control group

SHAM COMPARATOR
Other: Control group

Interventions

superficial cervical plexus nerve block will be performed under the guidance of ultrasound

Superficial cervical plexus block group

ultrasound guidance will be used to determine the location of superficial cervical plexus nerve. The puncture will also be performed by ultrasound guidance, covered with opaque infusion dressing but performed with infusion of 10 ml normal saline.

Control group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective suboccipital retrosigmoid approach approach craniotomy;
  • Age between 18 and 65 years;
  • American Society of Anesthesiologists (ASA) physical status I-III.

You may not qualify if:

  • The patients or legal clients refuse to provide informed consent;
  • Local infection;
  • Preoperative impairment of consciousness and cognitive function;
  • Uncontrolled hypertension;
  • Inability to communicate;
  • Allergies to experimental drugs;
  • History of drug abuse;
  • History of chronic headache;
  • Aphasia and hearing impairment;
  • Patients undergoing second craniotomy;
  • Body mass index \< 18.5 kg/m2 or \> 35.0 kg/m2;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Beijing Tiantan Hospital

Beijing, Beijing Municipality, 100050, China

Location

Beijing TianTan Hospital

Beijing, 100070, China

Location

Related Publications (2)

  • Zeng M, Li R, Xu X, Wang D, Dong J, Li S, Kass IS, Peng Y, Jia W. Ultrasound-guided superficial cervical plexus block reduces opioid consumption in patients undergoing craniotomy via suboccipital retrosigmoid approach: a randomized controlled trial. Reg Anesth Pain Med. 2022 Jun 29:rapm-2022-103534. doi: 10.1136/rapm-2022-103534. Online ahead of print.

  • Peng K, Zeng M, Dong J, Yan X, Wang D, Li S, Peng Y. Ultrasound-guided superficial cervical plexus block for analgesia in patients undergoing craniotomy via suboccipital retrosigmoid approach: study protocol of a randomised controlled trial. BMJ Open. 2020 Feb 5;10(2):e034003. doi: 10.1136/bmjopen-2019-034003.

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Yuming Peng, M.D.

    Beijing Tian Tan Hospital, Capital Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

July 26, 2019

First Posted

July 30, 2019

Study Start

November 18, 2019

Primary Completion

April 9, 2021

Study Completion

April 10, 2021

Last Updated

February 13, 2025

Record last verified: 2025-02

Locations